These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Intracisternal injection of somatostatin receptor 5-preferring agonists induces a vagal cholinergic stimulation of gastric emptying in rats. Martínez V; Rivier J; Coy D; Taché Y J Pharmacol Exp Ther; 2000 Jun; 293(3):1099-105. PubMed ID: 10869415 [TBL] [Abstract][Full Text] [Related]
4. Activation of somatostatin receptor subtype 2 inhibits acid secretion in rats. Lloyd KC; Wang J; Aurang K; Grönhed P; Coy DH; Walsh JH Am J Physiol; 1995 Jan; 268(1 Pt 1):G102-6. PubMed ID: 7840190 [TBL] [Abstract][Full Text] [Related]
5. Characterization of somatostatin receptor subtypes mediating inhibition of nutrient-stimulated gastric acid and gastrin in dogs. Fung LC; Greenberg GR Regul Pept; 1997 Feb; 68(3):197-203. PubMed ID: 9100287 [TBL] [Abstract][Full Text] [Related]
6. Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion? Taché Y; Rivier J; Vale W; Brown M Regul Pept; 1981 Feb; 1(5):307-15. PubMed ID: 6114519 [TBL] [Abstract][Full Text] [Related]
8. Somatostatin analogs and radiopeptides in cancer therapy. Froidevaux S; Eberle AN Biopolymers; 2002; 66(3):161-83. PubMed ID: 12385036 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154 [TBL] [Abstract][Full Text] [Related]
10. Reversal by NPY, PYY and 3-36 molecular forms of NPY and PYY of intracisternal CRF-induced inhibition of gastric acid secretion in rats. Gué M; Junien JL; Reeve JR; Rivier J; Grandt D; Taché Y Br J Pharmacol; 1996 May; 118(2):237-42. PubMed ID: 8735621 [TBL] [Abstract][Full Text] [Related]
11. Central action of somatostatin analog, SMS 201-995, to stimulate gastric acid secretion in rats. Yoneda M; Raybould H; Taché Y Peptides; 1991; 12(3):401-6. PubMed ID: 1923921 [TBL] [Abstract][Full Text] [Related]
12. Somatostatin antibody does not influence bombesin-induced inhibition of gastric acid secretion in rats. Martínez V; Yang H; Wong HC; Walsh JH; Taché Y Peptides; 1995; 16(1):1-6. PubMed ID: 7716060 [TBL] [Abstract][Full Text] [Related]
13. Somatostatin inhibition of acid and histamine release by activation of somatostatin receptor subtype 2 receptors in rats. Aurang K; Wang J; Lloyd KC J Pharmacol Exp Ther; 1997 Apr; 281(1):245-52. PubMed ID: 9103503 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin receptor subtype-5 mediates inhibition of peptide YY secretion from rat intestinal cultures. Chisholm C; Greenberg GR Am J Physiol Gastrointest Liver Physiol; 2000 Nov; 279(5):G983-9. PubMed ID: 11052995 [TBL] [Abstract][Full Text] [Related]
15. Effect of somatostatin analogs on gastric acid secretion in dogs and rats. Schally AV; Colaluca J; Paulson D; Carter WH; Neitzschman HR; Lafaye H; Cai RZ Int J Pept Protein Res; 1990 Sep; 36(3):267-74. PubMed ID: 1980670 [TBL] [Abstract][Full Text] [Related]
16. Central neuropeptide Y and the sigma ligand, JO 1784, reverse corticotropin-releasing factor-induced inhibition of gastric acid secretion in rats. Gué M; Yoneda M; Mönnikes H; Junien JL; Taché Y Br J Pharmacol; 1992 Nov; 107(3):642-7. PubMed ID: 1472962 [TBL] [Abstract][Full Text] [Related]
17. Intracisternal antisense oligodeoxynucleotides to the thyrotropin-releasing hormone receptor blocked vagal-dependent stimulation of gastric emptying induced by acute cold in rats. Martinez V; Wu SV; Taché Y Endocrinology; 1998 Sep; 139(9):3730-5. PubMed ID: 9724024 [TBL] [Abstract][Full Text] [Related]
18. Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats. Stengel A; Coskun T; Goebel M; Wang L; Craft L; Alsina-Fernandez J; Rivier J; Taché Y Endocrinology; 2010 Sep; 151(9):4224-35. PubMed ID: 20610566 [TBL] [Abstract][Full Text] [Related]
19. Suppression of ANP secretion by somatostatin through somatostatin receptor type 2. Gao S; Oh YB; Shah A; Park WH; Kim SH Peptides; 2011 Jun; 32(6):1179-86. PubMed ID: 21539874 [TBL] [Abstract][Full Text] [Related]
20. Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines. Arvigo M; Gatto F; Ruscica M; Ameri P; Dozio E; Albertelli M; Culler MD; Motta M; Minuto F; Magni P; Ferone D J Endocrinol; 2010 Dec; 207(3):309-17. PubMed ID: 20876239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]